Key result
Editorial provides commentary on the epidemic of primary aldosteronism without reporting original clinical data.
Answers are grounded in this paper and cite their sources.
Highlights the rising detection of primary aldosteronism in hypertension, indicating an urgent need for targeted screening to prevent vascular complications.
Department of Neurology and Clinical Pharmacology, University of Western Ontario and Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, London, Ontario, Canada. Correspondence and request for reprints to Dr J. David Spence, Professor of Neurology and Clinical Pharmacology, University of Western Ontario, and Director, Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, 1400 Western Road, London, Ontario N6G 2V2, Canada. Tel: +1519 663 3113; fax: +1519 663 3018; e-mail: [email protected]
No takes yet. Share an insight, caveat, or question.
J. David Spence (2004) conducted an editorial in Primary aldosteronism. The provided text contains only author affiliations and contact information, providing no clinical data regarding the epidemic of primary aldosteronism.
Synapse has enriched 10 related papers. Consider them for comparative context: